Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Horng-Mou Tsay"'
Autor:
Subbarao Mantha, Noor Turabi, Marc Ogan, Fred Yost, Horng-Mou Tsay, Elaine Jagoda, Bruce Stouffer, Jan-I Tu
Publikováno v:
Therapeutic drug monitoring. 15(3)
A specific and sensitive radioimmunoassay (RIA) for the measurement of SQ 33,600 in biological fluids has been developed. The assay utilizes a SQ 33,600 polyclonal antibody, [125I]iodohistamine-SQ 33,600 radiolabel, and standards in serum. Satisfacto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4f8c48c4c5f9f822b47b7e81aec27a
https://pubmed.ncbi.nlm.nih.gov/8333001
https://pubmed.ncbi.nlm.nih.gov/8333001
Autor:
Noor Turabi, Horng-Mou Tsay, Marc Ogan, Fred Yost, Subbarao Mantha, Elaine Jagoda, Jan-I Tu, Bruce Stouffer
Publikováno v:
Therapeutic drug monitoring. 14(6)
A specific and sensitive radioimmunoassay (RIA) for the measurement of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in biological fluids has been developed. The assay has a range of 2.5-1,000 ng/ml and 10-1,000 ng/ml for serum and uri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a51f25464b5bf28e77d827c05cd59d1
https://pubmed.ncbi.nlm.nih.gov/1485373
https://pubmed.ncbi.nlm.nih.gov/1485373
Publikováno v:
Investigative radiology. 25(7)
Hemolytic complement activity and a C3a radioimmunoassay (RIA) were investigated for their ability to characterize contrast media (CM) with respect to complement activation. The CM tested were commercial formulations of diatrizoate, iodamide, iothala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0662c0fa689cbc29b858646c2270a5d
https://pubmed.ncbi.nlm.nih.gov/2391195
https://pubmed.ncbi.nlm.nih.gov/2391195